SINTX Technologies, Inc.
corporate_fare Company Profile
SINTX Technologies, Inc. (NASDAQ:SINT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for SINT at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- First Human Surgery Performed with SINTX's FDA-Cleared SINAPTIC® Foot & Ankle Implant
- Sintx Technologies Appoints Ryan Elmore as President; CEO Eric Olson Retains Chairman Role
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$1.02M
Net Income
-$10.36M
Diluted EPS
-$6.16
Op. Cash Flow
-$8.57M
Free Cash Flow
-$8.76M
Gross Profit
$461K
Operating Income
-$10.72M
Cash & Equivalents
$4.14M
Total Debt
$7K
Debt / Equity
0.00×
Net Margin
-10.18×
Shares Outstanding
3.97M sh
Source: 10-K · filed 2026-03-20 · accession 0001493152-26-011924
show_chartPrice Chart
Loading chart...